SOUTH SAN FRANCISCO, Calif., March 19, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced the appointment of Paul V. Maier to its Board of Directors. His career has included senior financial leadership positions at Ligand Pharmaceuticals, DFS West, and ICN Pharmaceuticals.
